Oversold conditions and high volume — Injective gains 7.75%

Traders Union
All News
Crypto News
Injective jumps 7.75% to $3.73 today

Highlights

Injective recorded a 24-hour trading volume of $75.96 million as of 8:00 AM ET on February 1, indicating robust activity on major exchanges.
The platform maintains a market capitalization of approximately $358.92 million, with a nearly fully circulating supply of 99,970,935 tokens out of 100,000,000.
INJ trades at $3.73 below key moving averages, with resistance at $4.62–$4.76 and expected price action consolidating between $3.50 and $4.15 next week.

High trading activity as Injective sustains market cap and liquidity

Injective reported a 24-hour trading volume of $75.96 million as of 8:00 AM ET on February 1, highlighting significant market activity on major cryptocurrency exchanges. The platform maintains a market capitalization near $358.92 million, with a total supply of 100,000,000 tokens and a circulating supply of 99,970,935 tokens, supporting decentralized currency exchange operations since its launch in October 2020.

Persistent bearish momentum amid oversold indicators and weak support

Technical momentum for INJ remains broadly negative, with the closest dynamic support now at the Ichimoku Kijun ($4.52) and resistance overhead at both the MA-20 and MA-50 levels. The MACD and ADX indicate weak selling pressure, while the RSI, Stochastic RSI, and CCI all signal oversold conditions, reflecting a market stretched to the downside and continued seller dominance according to Bull/Bear Power. The Awesome Oscillator shows no clear trend, and mild divergence exists between the oversold oscillators and persistent bearish momentum.

Sideways to bearish expectation as volatility limits upside risk

For the week ahead, INJ is expected to trade within a $3.50 to $4.15 price corridor, representing a typical 10–12% volatility band relative to current levels and favoring a sideways to slightly bearish outlook. There is a low probability, below 20%, of a sustained upward move, making further decline more likely. The base scenario is continued consolidation between $3.50 and $4.15, while a decisive rise above $4.15 and recovery of the Ichimoku Kijun would be required for a bullish reversal; a break below support could result in new local lows beneath $3.50.

Anton Kharitonov, analyst at Traders Union, sees persistent technical weakness in Injective (INJ) as the price stays under key moving averages. He believes the oversold signals do little to improve the near-term outlook, with consolidation likely between $3.50 and $4.15. Short-term rallies remain suspect without a clear break above resistance. "I remain defensive on INJ as long as the price stays below $4.15 — the base case favors more sideways or downside movement."

Previously it was reported that Injective continues to exhibit strong bearish momentum, trading well below major moving averages and encountering resistance at $4.91, as oversold signals and key momentum indicators highlight persistent selling pressure. The asset is expected to consolidate between $3.34 and $3.96 in the near term, with downside risk prevailing unless a sustained move above resistance occurs.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.